Low Potency of Indian Dust Mite Allergen Skin Prick Test Extracts Compared to FDA-Approved Extracts: A Double-Blinded Randomized Control Trial | Zendy

Devasahayam Jesudas Christopher | Zendy; Narmada Ashok | Zendy; Aruna Ravivarma | Zendy; Deepa Shankar | Zendy; Erik Peterson | Zendy; Phuong Dinh | Zendy; Pudupakkam K. Vedanthan | Zendy

Open Access

Low Potency of Indian Dust Mite Allergen Skin Prick Test Extracts Compared to FDA-Approved Extracts: A Double-Blinded Randomized Control Trial

Author(s) -

Devasahayam Jesudas Christopher,

Narmada Ashok,

Aruna Ravivarma,

Deepa Shankar,

Erik Peterson,

Phuong Dinh,

Pudupakkam K. Vedanthan

Publication year - 2018

Publication title -

allergy and rhinology

Language(s) - English

Resource type - Journals

eISSN - 2152-6575

pISSN - 2152-6567

DOI - 10.1177/2152656718796746

Subject(s) - medicine , allergen , potency , serial dilution , house dust mite , allergy , mite , veterinary medicine , traditional medicine , immunology , biology , botany , in vitro , pathology , biochemistry , alternative medicine

The indigenous extracts have significantly lower potency compared to USFDA-approved extracts; hence, there is an urgent need for policy makers to institute stringent criteria for standardization of antigens in India.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog